Research & Literature

Neuro-ophthalmologic exploration in non-functioning pituitary adenoma.

Abouaf L, Vighetto A, Lebas M

Annales d'endocrinologie 2015; (76(3)):210-9.

Post-surgical management of non-functioning pituitary adenoma.

Cortet-Rudelli C, Bonneville JF, Borson-Chazot F, et al.

Annales d'endocrinologie 2015; (76(3)):228-38.

Endoscopic endonasal management of non-functioning pituitary adenomas with cavernous sinus invasion: a 10- year experience.

Ferreli F, Turri-Zanoni M, Canevari FR, et al.

Rhinology 2015; (53(4)):308-16 doi:10.4193/Rhino14.309.

Clinical characteristics and risk factors for headache associated with non-functioning pituitary adenomas.

Yu B, Ji N, Ma Y, et al.

Cephalalgia : an international journal of headache 2017; (37(4)):348-355 doi:10.1177/0333102416648347.

Clinical Concerns about Recurrence of Non-Functioning Pituitary Adenoma.

Lee MH, Lee JH, Seol HJ, et al.

Brain tumor research and treatment 2016; (4(1)):1-7 doi:10.14791/btrt.2016.4.1.1.

Stereotactic radiotherapy and radiosurgery for non-functioning and secreting pituitary adenomas.

Minniti G, Clarke E, Scaringi C, Enrici RM

Reports of practical oncology and radiotherapy : journal of Greatpoland Cancer Center in Poznan and Polish Society of Radiation Oncology 2016; (21(4)):370-8 doi:10.1016/j.rpor.2014.09.004.

Relationship of each anterior pituitary hormone deficiency to the size of non-functioning pituitary adenoma in the hospitalized patients.

Mukai K, Kitamura T, Tamada D, et al.

Endocrine journal 2016; (63(11)):965-976 doi:10.1507/endocrj.EJ16-0168.

Is Positive Staining of Non-Functioning Pituitary Adenomas for Luteinizing Hormone Associated with a Poor Prognosis?

Diri H, Ozaslan E, Kurtsoy A, et al.

Turkish neurosurgery 2017; (27(1)):8-13 doi:10.5137/1019-5149.JTN.14889-15.1.

Congress of Neurological Surgeons Systematic Review and Evidence-Based Guideline for the Management of Patients With Residual or Recurrent Nonfunctioning Pituitary Adenomas.

Sheehan J, Lee CC, Bodach ME, et al.

Neurosurgery 2016; (79(4)):E539-40 doi:10.1227/NEU.0000000000001385.

Target delineation and optimal radiosurgical dose for pituitary tumors.

Minniti G, Osti MF, Niyazi M

Radiation oncology (London, England) 2016; (11(1)):135 doi:10.1186/s13014-016-0710-y.

Life expectancy in patients with pituitary adenoma receiving growth hormone replacement.

Olsson DS, Trimpou P, Hallén T, et al.

European journal of endocrinology 2017; (176(1)):67-75 doi:10.1530/EJE-16-0450.

Therapeutic Strategy for Cavernous Sinus-Invading Non-Functioning Pituitary Adenomas Based on the Modified Knosp Grading System.

Hwang J, Seol HJ, Nam DH, et al.

Brain tumor research and treatment 2016; (4(2)):63-69 doi:10.14791/btrt.2016.4.2.63.

Co-occurrence of Pituitary Adenoma with Suprasellar and Olfactory Groove Meningiomas.

Lim KZ, Goldschlager T, Chandra RV, et al.

Basic and clinical neuroscience 2016; (7(4)):361-365 doi:10.15412/J.BCN.03070409.

Vanishing Pituitary Macroadenoma: A Case Report.

Sieg EP, Stepanyan H, Payne R, et al.

Cureus 2016; (8(10)):e838 doi:10.7759/cureus.838.

Higher glucocorticoid replacement doses are associated with increased mortality in patients with pituitary adenoma.

Hammarstrand C, Ragnarsson O, Hallén T, et al.

European journal of endocrinology 2017; (177(3)):251-256.

Clinically non-functioning pituitary adenomas: Pathogenic, diagnostic and therapeutic aspects.

Mercado M, Melgar V, Salame L, Cuenca D

Endocrinologia, diabetes y nutricion 2017; (64(7)):384-395 doi:10.1016/j.endinu.2017.05.009.

Prevalence, Clinical Features, and Natural History of Incidental Clinically Non-Functioning Pituitary Adenomas.

Iglesias P, Arcano K, Triviño V, et al.

Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme 2017; (49(9)):654-659 doi:10.1055/s-0043-115645.

Overview of the 2017 WHO Classification of Pituitary Tumors.

Mete O, Lopes MB

Endocrine pathology 2017; (28(3)):228-243 doi:10.1007/s12022-017-9498-z.

Radiologic Predictors for Extent of Resection in Pituitary Adenoma Surgery. A Single-Center Study.

Sanmillán JL, Torres-Diaz A, Sanchez-Fernández JJ, et al.

World neurosurgery 2017; (108()):436-446 doi:10.1016/j.wneu.2017.09.017.

Clinical characteristics and ophthalmologic findings of pituitary adenoma in Korean patients.

Kim TG, Jin KH, Kang J

International ophthalmology 2019; (39(1)):21-31 doi:10.1007/s10792-017-0778-x.

Mid-term prognosis of non-functioning pituitary adenomas with high proliferative potential: really an aggressive variant?

Ogawa Y, Jokura H, Niizuma K, Tominaga T

Journal of neuro-oncology 2018; (137(3)):543-549 doi:10.1007/s11060-017-2740-1.

Management of NFAs: medical treatment.

Even-Zohar N, Greenman Y

Pituitary 2018; (21(2)):168-175 doi:10.1007/s11102-018-0865-7.

Epidemiology, clinical presentation and diagnosis of non-functioning pituitary adenomas.

Ntali G, Wass JA

Pituitary 2018; (21(2)):111-118 doi:10.1007/s11102-018-0869-3.

Pediatric Cushing's Disease: Dichotomy in Lateralization between Imaging and Inferior Petrosal Sinus Sampling with Review of Literature.

Shaikh ST, Karmarkar VS, Deopujari CE

Journal of pediatric neurosciences 2017; (12(4)):349-352 doi:10.4103/jpn.JPN_57_17.

Coexistent Pituitary Adenoma with Rathke's Cleft Cyst: A Case Series.

Jagtap VS, Lila AR, Sarathi V, et al.

The Journal of the Association of Physicians of India 2018; (66(3)):42-6.

A two‑circRNA signature predicts tumour recurrence in clinical non‑functioning pituitary adenoma.

Guo J, Wang Z, Miao Y, et al.

Oncology reports 2019; (41(1)):113-124 doi:10.3892/or.2018.6851.

Ki-67 labeling index in glioblastoma; does it really matter?

Alkhaibary A, Alassiri AH, AlSufiani F, Alharbi MA

Hematology/oncology and stem cell therapy 2019; (12(2)):82-88 doi:10.1016/j.hemonc.2018.11.001.

Comparison of Short-Term Outcomes Between Endoscopic and Microscopic Trans-Sphenoidal Surgery for the Treatment of Pituitary Adenoma.

Li J, Ding W, Huang Z, et al.

The Journal of craniofacial surgery 2019; (30(8)):2421-2424 doi:10.1097/SCS.0000000000005676.

Chronic chiasmal compression and persistent visual field defect without detectable changes in optical coherence tomography of the macular ganglion cell complex.

Lukewich MK, Micieli JA

American journal of ophthalmology case reports 2019; (16()):100533 doi:10.1016/j.ajoc.2019.100533.

[Ectopic pituitary adenoma associated with empty sella turcica].

Zelaya MV, Bacaicoa C, Zazpe I, Gomez Dorronsoro M

Revista espanola de patologia : publicacion oficial de la Sociedad Espanola de Anatomia Patologica y de la Sociedad Espanola de Citologia 2019; (52(4)):256-259 doi:10.1016/j.patol.2018.06.003.

Cut-off values for sufficient cortisol response to low dose Short Synacthen Test after surgery for non-functioning pituitary adenoma.

Kolnes AJ, Øystese KA, Dahlberg D, et al.

Acta neurochirurgica 2020; (162(4)):845-852 doi:10.1007/s00701-019-04068-z.

Growth Hormone Therapy Does Not Increase the Risk of Craniopharyngioma and Nonfunctioning Pituitary Adenoma Recurrence.

Losa M, Castellino L, Pagnano A, et al.

The Journal of clinical endocrinology and metabolism 2020; (105(5)) doi:10.1210/clinem/dgaa089.

The optimal numerosity of the referral population of pituitary tumors centers of excellence (PTCOE): A surgical perspective.

Mortini P, Nocera G, Roncelli F, et al.

Reviews in endocrine & metabolic disorders 2020; (21(4)):527-536 doi:10.1007/s11154-020-09564-7.

Identification of a multidimensional transcriptome signature predicting tumor regrowth of clinically non‑functioning pituitary adenoma.

Cheng S, Guo J, Zhang Y, et al.

International journal of oncology 2020; (57(3)):804-812 doi:10.3892/ijo.2020.5087.

Newer Concepts in the Classification of Pituitary Adenomas.

Sathyakumar R, Chacko G

Neurology India 2020; (68(Supplement)):S7-S12 doi:10.4103/0028-3886.287667.

Health-related quality of life in patients with non-functioning pituitary adenoma: a special focus on hydrocortisone replacement dose.

Wild CM, Stieg M, Stalla GK, et al.

Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation 2020; (29(12)):3325-3331 doi:10.1007/s11136-020-02582-7.

MRI radiomics for the prediction of recurrence in patients with clinically non-functioning pituitary macroadenomas.

Machado LF, Elias PCL, Moreira AC, et al.

Computers in biology and medicine 2020; (124()):103966 doi:10.1016/j.compbiomed.2020.103966.

Incidence, mortality, and cardiovascular diseases in pituitary adenoma in Korea: a nationwide population-based study.

Oh JS, Kim HJ, Hann HJ, et al.

Pituitary 2021; (24(1)):38-47 doi:10.1007/s11102-020-01084-6.

The Role of T-box Transcription Factor in a Pituitary Adenoma Diagnostic Algorithm.

McDonald WC, McDonald KN, Helmer JA, et al.

Archives of pathology & laboratory medicine 2021; (145(5)):592-598 doi:10.5858/arpa.2020-0091-OA.

Characteristics and clinical outcomes in pituitary incidentalomas and non-incidental pituitary tumors treated with endoscopic transsphenoidal surgery.

Morinaga Y, Abe I, Nii K, et al.

Medicine 2020; (99(44)):e22713 doi:10.1097/MD.0000000000022713.

Transcriptome and methylome analysis reveals three cellular origins of pituitary tumors.

Taniguchi-Ponciano K, Andonegui-Elguera S, Peña-Martínez E, et al.

Scientific reports 2020; (10(1)):19373 doi:10.1038/s41598-020-76555-8.

Chromosomal and oxidative DNA damage in non-functioning pituitary adenomas.

Bitgen N, Bayram F, Hamurcu Z, et al.

Endokrynologia Polska 2021; (72(2)):97-103 doi:10.5603/EP.a2020.0084.

Dome-Shaped Pituitary Enlargement in Primary Hypothyroidism: Avoiding Neurosurgical Interventions.

Chakraborty S, Tiwari M, Palui R, et al.

Journal of the ASEAN Federation of Endocrine Societies 2020; (35(2)):238-243 doi:10.15605/jafes.035.02.14.

Comparison of outcomes between endoscopic and microscopic transsphenoidal surgery for the treatment of pituitary adenoma: a meta-analysis.

Chen X, Huang W, Li H, et al.

Gland surgery 2020; (9(6)):2162-2174 doi:10.21037/gs-20-851.

Neuropathology of Pituitary Adenomas and Sellar Lesions.

Kobalka PJ, Huntoon K, Becker AP

Neurosurgery 2021; (88(5)):900-918 doi:10.1093/neuros/nyaa548.

Aggressive Pituitary Adenoma Not Fulfilling the New High-Risk Criteria with Progression after 18-Year Stable Clinical Course: Case Report.

Kawaguchi T, Ogawa Y, Watanabe M, Tominaga T

Journal of neurological surgery. Part A, Central European neurosurgery 2022; (83(4)):391-395 doi:10.1055/s-0040-1722195.

Nomogram predictive model of post-operative recurrence in non-functioning pituitary adenoma.

Lyu W, Fei X, Chen C, Tang Y

Gland surgery 2021; (10(2)):807-815 doi:10.21037/gs-21-47.

A comparative study of functioning and non-functioning pituitary adenomas.

Qin J, Li K, Wang X, Bao Y

Medicine 2021; (100(14)):e25306 doi:10.1097/MD.0000000000025306.

A Meta-Analysis of Endoscopic vs. Microscopic Transsphenoidal Surgery for Non-functioning and Functioning Pituitary Adenomas: Comparisons of Efficacy and Safety.

Guo S, Wang Z, Kang X, et al.

Frontiers in neurology 2021; (12()):614382 doi:10.3389/fneur.2021.614382.

Non-functioning pituitary adenomas and pregnancy: one-center experience and review of the literature.

Rosmino J, Tkatch J, Di Paolo MV, et al.

Archives of endocrinology and metabolism 2021; (64(5)):614-622.

Acute Sterile Meningitis as a Primary Manifestation of Pituitary Apoplexy.

Tumyan G, Mantha Y, Gill R, Feldman M

AACE clinical case reports 2021; (7(2)):117-120 doi:10.1016/j.aace.2020.11.024.

Recommendations on the pathological report of pituitary tumors. A consensus of experts of the Spanish Society of Endocrinology and Nutrition and the Spanish Society of Pathology.

Picó A, Aranda-López I, Sesmilo G, et al.

Endocrinologia, diabetes y nutricion 2021; (68(3)):196-207 doi:10.1016/j.endien.2020.10.007.

Giant Recurrence Pituitary Adenoma After Three Times Transphenoidal Removal Surgery, One Craniotomy Procedure, and 30 Doses of External Radiotherapy.

Pramono LA, Yunir E, Tarigan TJE, et al.

Acta medica Indonesiana 2021; (53(2)):221-224.

Predictive factors of postoperative diabetes insipidus in 333 patients undergoing transsphenoidal surgery for non-functioning pituitary adenoma.

Kinoshita Y, Taguchi A, Tominaga A, et al.

Pituitary 2022; (25(1)):100-107 doi:10.1007/s11102-021-01175-y.

Clinically non-functioning pituitary adenomas.

Chanson P, Wolf P

Presse medicale (Paris, France : 1983) 2021; (50(4)):104086 doi:10.1016/j.lpm.2021.104086.

The role of OCT- angiography in predicting anatomical and functional recovery after endoscopic endonasal pituitary surgery: A 1-year longitudinal study.

Cennamo G, Solari D, Montorio D, et al.

PloS one 2021; (16(12)):e0260029 doi:10.1371/journal.pone.0260029.

An Update on Silent Corticotroph Adenomas: Diagnosis, Mechanisms, Clinical Features, and Management.

Jiang S, Chen X, Wu Y, et al.

Cancers 2021; (13(23)) doi:10.3390/cancers13236134.

The natural history of non-functioning pituitary adenomas: A meta-analysis of conservatively managed tumors.

Pernik MN, Montgomery EY, Isa S, et al.

Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia 2022; (95()):134-141 doi:10.1016/j.jocn.2021.12.003.

Approach to the Patient: Differential Diagnosis of Cystic Sellar Lesions.

Gadelha MR, Wildemberg LE, Lamback EB, et al.

The Journal of clinical endocrinology and metabolism 2022; (107(6)):1751-1758 doi:10.1210/clinem/dgac033.

Comparative Evaluation of Two SD-OCT Macular Parameters (GCC, GCL) and RNFL in Chiasmal Compression.

Santorini M, Ferreira De Moura T, Barraud S, et al.

Eye and brain 2022; (14()):35-48 doi:10.2147/EB.S337333.

Overview of the 2022 WHO Classification of Pituitary Tumors.

Asa SL, Mete O, Perry A, Osamura RY

Endocrine pathology 2022; (33(1)):6-26 doi:10.1007/s12022-022-09703-7.

A review of multiomics platforms in pituitary adenoma pathogenesis.

Mouchtouris N, Smit RD, Piper K, et al.

Frontiers in bioscience (Landmark edition) 2022; (27(3)):77 doi:10.31083/j.fbl2703077.

Treatment of non-functioning pituitary adenoma with cabergoline: a systematic review and meta-analysis.

Botelho MS, Franzini ÍA, Nunes-Nogueira VDS, Boguszewski CL

Pituitary 2022; (25(6)):810-818 doi:10.1007/s11102-022-01257-5.

Endoscopic transsphenoidal surgery for non-functioning pituitary adenoma: Learning curve and surgical results in a prospective series during initial experience.

Boetto J, Joitescu I, Raingeard I, et al.

Frontiers in surgery 2022; (9()):959440 doi:10.3389/fsurg.2022.959440.

A Factorial Analysis on Visual Outcomes of Transsphenoidal Surgery for Pituitary Macroadenoma.

Ng BCF, Mak CH, Steffi CSY, et al.

Asian journal of neurosurgery 2022; (17(2)):280-285 doi:10.1055/s-0042-1751011.

Effect of cabergoline on tumor remnant after surgery in nonfunctioning pituitary adenoma.

Iglesias P, Biagetti B, Araujo-Castro M, et al.

Journal of neuro-oncology 2022; (160(2)):351-359 doi:10.1007/s11060-022-04149-7.

Imaging of pituitary tumors: an update with the 5th WHO Classifications-part 1. Pituitary neuroendocrine tumor (PitNET)/pituitary adenoma.

Tsukamoto T, Miki Y

Japanese journal of radiology 2023; (41(8)):789-806 doi:10.1007/s11604-023-01400-7.

Evaluation of preoperative visual pathway impairment in patients with non-functioning pituitary adenoma using diffusion tensor imaging coupled with optical coherence tomography.

Pang Y, Tan Z, Chen X, et al.

Frontiers in neuroscience 2023; (17()):1057781 doi:10.3389/fnins.2023.1057781.

Coping With 'Scanxiety': Within-Person Processes in Lung Cancer.

Dunsmore VJ, Neupert SD

Psychological reports 2025; (128(2)):702-722 doi:10.1177/00332941231164336.

Low Bone Density and High Sclerostin in Non-Functioning Pituitary Adenoma.

Pekkolay Z, Yıldırım DV, Tuzcu ŞA, et al.

Journal of clinical densitometry : the official journal of the International Society for Clinical Densitometry 2023; (26(2)):101363 doi:10.1016/j.jocd.2023.03.002.

The impact of transsphenoidal surgery on pituitary function in patients with non-functioning macroadenomas.

Mavromati M, Mavrakanas T, Jornayvaz FR, et al.

Endocrine 2023; (81(2)):340-348 doi:10.1007/s12020-023-03400-z.

Healthcare cost and survival in patients with non-functioning pituitary adenoma.

Olsson DS, Svensson M, Labori F, et al.

European journal of endocrinology 2023; (188(6)):477-484 doi:10.1093/ejendo/lvad057.

Sleep quality in patients with non-functioning pituitary adenoma: impact of replacement therapies with an emphasis on the time of hydrocortisone.

Barlas T, Yalcin MM, Avci DE, et al.

Pituitary 2023; (26(4)):411-418 doi:10.1007/s11102-023-01328-1.

Plurihormonal Pituitary Neuroendocrine Tumours - A Single Centre Experience.

Mihajlović M, Pekić S, Doknić M, et al.

International journal of surgical pathology 2024; (32(3)):470-477 doi:10.1177/10668969231183712.

[WHO Histological Classification of Pituitary Tumors].

Nishioka H

No shinkei geka. Neurological surgery 2023; (51(4)):642-653 doi:10.11477/mf.1436204797.

Pituitary Neuroendocrine Tumor: Is It Benign or Malignant?

Lee CH

Brain tumor research and treatment 2023; (11(3)):173-176 doi:10.14791/btrt.2023.0015.

Pituitary adenoma or neuroendocrine tumour: the need for an integrated prognostic classification.

Ho KKY, Kaiser UB, Chanson P, et al.

Nature reviews. Endocrinology 2023; (19(11)):671-678 doi:10.1038/s41574-023-00883-8.

[Histological Classification and Diagnosis of Sellar/Parasellar Tumors].

Nishioka H

No shinkei geka. Neurological surgery 2023; (51(5)):789-798 doi:10.11477/mf.1436204820.

[Overview of the New World Health Organization Classification of Pituitary Neuroendocrine Tumors].

Kurosaki M

No shinkei geka. Neurological surgery 2023; (51(5)):910-916 doi:10.11477/mf.1436204833.

Ectopic pituitary adenoma with empty sella: A case report.

Iliass B, Khaoula B, Selma K, et al.

SAGE open medical case reports 2024; (12()):2050313X231223465 doi:10.1177/2050313X231223465.

Scanxiety and quality of life around follow-up imaging in patients with unruptured intracranial aneurysms: a prospective cohort study.

Kamphuis MJ, van der Kamp LT, van Eijk RPA, et al.

European radiology 2024; (34(9)):6018-6025 doi:10.1007/s00330-024-10602-0.

Headache in patients with non-functioning pituitary adenoma before and after transsphenoidal surgery - a prospective study.

Hantelius V, Ragnarsson O, Johannsson G, et al.

Pituitary 2024; (27(5)):635-643 doi:10.1007/s11102-024-01401-3.

Magnetic Resonance Imaging Features of the Sphenoid Sinus in Patients with Non-Functioning Pituitary Adenoma.

Ciurea MV, Florian IȘ, Lenghel M, et al.

Medicina (Kaunas, Lithuania) 2024; (60(5)) doi:10.3390/medicina60050708.

High prevalence of morphometric vertebral fractures opportunistically detected on thoracic radiograms in patients with non-functioning pituitary adenoma.

Frara S, Uygur MM, Bolamperti F, et al.

Pituitary 2024; (27(4)):370-380 doi:10.1007/s11102-024-01394-z.

Clinical implications of the 2022 WHO classification on the multidisciplinary management of PitNETS patients.

Veleno M, Giampietro A, Raia S, et al.

Minerva endocrinology 2024; (49(3)):269-282 doi:10.23736/S2724-6507.24.04126-5.

A nonsecreting suprasellar ectopic pituitary adenoma: A case report.

Sqalli Houssaini A, Essetti S, Zebbakh H, et al.

Radiology case reports 2024; (19(12)):5963-5966 doi:10.1016/j.radcr.2024.09.023.

GH-Secreting Adenoma or Tumor? Issues in Pituitary Neoplasms Nomenclature, Classification, and Characterization.

Guaraldi F, Di Sciascio L, Shwaish TZT, et al.

Frontiers of hormone research 2024; (55()):119-132 doi:10.1159/000539946.

Knosp and revised Knosp classifications predict non-functioning pituitary adenoma outcomes: a single tertiary center experience.

Rouf S, Berrabeh S, Zarraa L, Latrech H

Journal of medicine and life 2024; (17(11)):1007-1011 doi:10.25122/jml-2024-0015.

A multi-site feasibility study of a stepped-care telehealth intervention for depression and anxiety in post-treatment cancer survivors at community cancer clinics (WF-30917CD).

Danhauer SC, Brenes GA, Weaver KE, et al.

Journal of cancer survivorship : research and practice 2025; doi:10.1007/s11764-024-01721-0.

Multiple microcysts and clivus invasion diagnose T-box pituitary transcription factor 19 lineage adenomas in non-functioning pituitary adenomas.

Zhao X, Wang X, Wang S, et al.

Acta radiologica (Stockholm, Sweden : 1987) 2025; (66(4)):441-449 doi:10.1177/02841851251313555.

Outcomes of transsphenoidal surgery for pituitary adenomas in Spain: a retrospective multicenter study.

Paja M, Soto A, Hanzu FA, et al.

Frontiers in endocrinology 2025; (16()):1529418 doi:10.3389/fendo.2025.1529418.

Tumor Control and Long-Term Survival in Non-Functional Pituitary Adenoma Treated with Adjuvant Radiotherapy. A Retrospective Single Institutional Study.

Saju AC, Krishnatry R, Goda JS, et al.

Neurology India 2025; (73(2)):257-263 doi:10.4103/neurol-india.Neurol-India-D-24-00110.

Progress in the pathogenesis and treatment of pituitary neuroendocrine tumors (PitNETs): From molecular mechanisms to emerging therapies.

Wu N, Wu N, Wang N, Zhu Y

Molecular and cellular probes 2025; (83()):102039 doi:10.1016/j.mcp.2025.102039.

Long-Term Functional and Tumor Outcomes Following Uni-Nostril Endoscopic Surgery for Non-Functioning Pituitary Adenomas: Results in 172 Patients.

Baldia M, D'Souza WP, Girishan S, et al.

Neurology India 2025; (73(1)):55-63 doi:10.4103/neurol-india.Neurol-India-D-23-00640.

Management of Recurrent and Aggressive Non-Functioning Pituitary Adenomas.

Hefner NA, Cooper O

Journal of clinical medicine 2025; (14(15)) doi:10.3390/jcm14155203.

Neurocognitive evaluation of patients with non-functioning pituitary adenoma.

Altinbezer A, Barlas T, Aksu MH, et al.

Pituitary 2025; (28(5)):105 doi:10.1007/s11102-025-01582-5.